D-Sight is developing a first-in-class neuroprotective eye drop designed to treat retinal diseases at their earliest stages, when vision can still be preserved.

 

Our non-invasive approach targets the underlying neurodegeneration driving disease progression, offering the potential to transform current care beyond late, invasive interventions. Initially focused on diabetic retinopathy and expanding into glaucoma.​